MTOR and Alzheimer disease: Our findings suggest that mTOR may be a therapeutic target to restore cerebrovascular function during normative aging and that mTOR inhibitors may help decrease the risk of developing age‐associated disorders including vascular‐type dementia and AD (Jahrling et al., 2018; Van Skike et al., 2018).